- 全部删除
- 您的购物车当前为空
AZ084 是可口服的选择性 CCR8变构拮抗剂,其Ki 值为 0.9 nM,可研究哮喘。
为众多的药物研发团队赋能,
让新药发现更简单!
AZ084 是可口服的选择性 CCR8变构拮抗剂,其Ki 值为 0.9 nM,可研究哮喘。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 648 | In stock | |
5 mg | ¥ 1,530 | In stock | |
10 mg | ¥ 2,320 | In stock | |
25 mg | ¥ 3,750 | In stock | |
50 mg | ¥ 5,130 | In stock | |
100 mg | ¥ 6,900 | In stock | |
200 mg | ¥ 9,280 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 1,490 | In stock |
AZ084 相关产品
产品描述 | AZ084 is a potent, selective, allosteric, and oral active CCR8 antagonist (Ki: 0.9 nM). It has the potential to treat asthma. |
靶点活性 | CCR8:0.9 nM (ki) |
分子量 | 434.57 |
分子式 | C26H34N4O2 |
CAS No. | 929300-19-6 |
Smiles | CC1(C)Cc2c(O1)cccc2CN1CCC2(CC1)CCN(CC2)C(=O)c1ccc(N)cn1 |
密度 | 1.24 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 240 mg/mL (552.27 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容